Catalyst Wire Dossier Catalyst Wire Dossier

Flonoltinib Maleate Tablet

flonoltinib maleate · Chengdu Zenitar Biomedical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flonoltinib Maleate Tablet, covering 2025-04-10 to 2025-04-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis [Phase 2]

See pricing